KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Shares Issued (2016 - 2025)

Historic Shares Issued for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to $7.2 million.

  • Inovio Pharmaceuticals' Shares Issued rose 97712.4% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.1 million, marking a year-over-year increase of 8610.38%. This contributed to the annual value of $60.8 million for FY2024, which is 101319.73% up from last year.
  • According to the latest figures from Q3 2025, Inovio Pharmaceuticals' Shares Issued is $7.2 million, which was up 97712.4% from $1.1 million recorded in Q1 2025.
  • Inovio Pharmaceuticals' Shares Issued's 5-year high stood at $162.1 million during Q1 2021, with a 5-year trough of $667066.0 in Q3 2024.
  • Moreover, its 5-year median value for Shares Issued was $6.7 million (2022), whereas its average is $24.5 million.
  • Its Shares Issued has fluctuated over the past 5 years, first tumbled by 9324.52% in 2023, then surged by 195888.5% in 2024.
  • Over the past 5 years, Inovio Pharmaceuticals' Shares Issued (Quarter) stood at $47.3 million in 2021, then tumbled by 85.91% to $6.7 million in 2022, then crashed by 72.43% to $1.8 million in 2023, then soared by 1958.89% to $37.8 million in 2024, then tumbled by 81.02% to $7.2 million in 2025.
  • Its last three reported values are $7.2 million in Q3 2025, $1.1 million for Q1 2025, and $37.8 million during Q4 2024.